The proportions of NORA cases among all cases included in the analysis are presented in Figure 2A. The proportion of NORA cases increased from 28.3% in 2010 to 35.9% in 2014 (P < .001). There was a significant upward trend in the proportion of NORA among all cases reported to NACOR—odds ratio of 1.08 for NORA versus OR during each year of the study period (95% confidence interval [CI] 1.08–1.08, P < .001) in the multivariable analysis that included facility type and urban/rural location as covariables. The absolute number of NORA cases reported to NACOR was 632,134 in 2010 and 1,955,542 in 2014.
The mean age of NORA patients was 3.5 years higher compared with OR patients (95% CI 3.5–3.5, P < .001). Comparisons of individual age strata demonstrated that there also were differences in patient age distribution between NORA and OR (Table 1). There were no clinically significant differences in sex distribution between NORA and OR groups. The proportion of patients with ASA PS class III–V was greater in the NORA group compared with OR group, at 37.6% and 33.0%, respectively (P < .001).
The proportions of cases performed in different facility types and rural versus urban locations were statistically significantly different between NORA and OR groups, but the difference was small (Table 1). The median (quartiles 1, 3) duration of NORA cases was 40 (25, 70) minutes compared with 86 (52, 141) minutes for OR cases (P < .001); the median duration of NORA gastroenterology cases was 32 (23, 45) minutes. In comparison to OR cases, more NORA cases were started after normal working hours (9.9% vs 16.7%, P < .001).
Time trend analysis of NORA cases demonstrated considerable variation in patient and case characteristics during the 5-year study period. The mean age of NORA patients was 51.5 years in 2010 and 55.0 years in 2014, with an increase of 3.5 years (95% CI 3.4–3.5, P < .001; Figure 2B). In the univariable analysis, there was a significant upward trend in the mean age of NORA patients with an increase of 0.87 years of age (slope 0.87; 95% CI 0.86–0.89, P < .001) per each year of the study period. The multivariable analysis that included facility type and urban/rural location as covariables demonstrated that the mean age of NORA patients increased by 1.06 years (slope 1.06; 95% CI 1.05–1.07, P < .001) per year of study period. In the multivariable analysis, the mean age of OR patients increased by 0.66 years (slope 0.66; 95% CI 0.65–0.67, P < .001) per year of study period. The upward trend in mean age was significantly greater in NORA patients compared with OR patients, with a difference in slopes of 0.39 years per year of study period (95% CI 0.38–0.41, P < .001) in the multivariable analysis.
The proportion of patients with ASA PS III–V among NORA cases was 36.5% in 2010 and 38.8% in 2014 (Figure 2C). In a multivariable analysis that included facility type and urban/rural location as covariables, the annual increase in ordinal ASA PS scale in NORA group was small in magnitude, but statistically significant—odds ratio of 1.04 for increase in one unit of ASA PS scale per year of study period (95% CI 1.04–1.05, P < .001). The multivariable analysis also demonstrated that the upward trend in ordinal ASA PS scale was greater in NORA group compared with OR group (ratio of odds ratios 1.004; 95% CI 1.003–1.006, P < .001), but this difference was not clinically important.
Among all NORA cases, the proportion of outpatient cases increased from 69.7% in 2010 to 73.3% in 2014 (P < .001). A multivariable analysis that included facility type and urban/rural location as covariables demonstrated a small in magnitude upward trend in the proportion of outpatient cases in the NORA group—an odds ratio of 1.07 for outpatient versus inpatient during each year of the study period (95% CI 1.07–1.07, P < .001). There was no clinically significant difference between trends in proportions of outpatient cases in NORA and OR groups, although the upward trend was greater in the NORA group (ratio of odds ratios 1.04; 95% CI 1.04–1.04, P < .001). In the sensitivity analyses, we identified time trends of the same direction and comparable magnitude: (1) in NACOR cases that were excluded from the main study and (2) in NORA cases from practices that submitted cases for each year of the observation period. The annual proportions of the most frequently reported procedures that required NORA care are presented in Table 3.
The results of this study offer a contemporary insight into nonoperating room anesthesia care in the United States based on recent data from NACOR and suggest ways in which data collection needs to be improved. Although information on the location of anesthesia care was missing in a considerable number of cases, available data suggest that approximately one third of all cases reported to NACOR are NORA cases. The proportion of cases performed outside of the OR demonstrates a steady increase during the period of 2010–2014. Compared with OR patients, NORA patients are older. We have identified upward trends in the age of both NORA and OR patients, but NORA patients were becoming older significantly faster compared with OR patients, even after adjustment for facility type and urban/rural location. The proportion of patients with ASA PS III–V was greater in NORA than in the OR. On the whole, NORA cases took half the time of OR cases and were more likely to be started after normal working hours. Among NORA cases with specified location, most were performed in the gastroenterology suite. Anesthesia for colonoscopy was the most common procedure-specific type of NORA.
The results of this study, in general, fall in line with the very limited existing literature that focuses on NORA. A strong upward trend in the proportion of NORA cases in NACOR observed in this study is consistent with an earlier report of more than doubling of the number of NORA cases from 2003 to 2012 in an individual pediatric hospital.12 An increase in the proportion of NORA cases also parallels a similar increase in the proportion of outpatient surgeries that has been measured over 2 decades.13 An increase in provision of NORA care may reflect an emphasis on endoscopic screening for colon cancer and advanced endovascular diagnostic and therapeutic approaches, as well as development of percutaneous approaches to treatments that were previously performed only in a surgical setting. If the increase we observed reflects the nationwide trend, and if such a trend continues over the coming years, it is possible that the number of NORA cases may approach or even exceed the number of OR cases. A more robust system of data collection and analysis would be required to make accurate assessments and projections. This would allow us to reframe the fundamental vision of anesthesiology to include emerging markets in non-OR areas.
The growth of NORA cases indicates the increasing role of NORA in the overall efficiency of anesthesia care. Development of consistent pre and postprocedural platforms for NORA patients may improve not only safety, but also efficiency and ergonomics.14,15 For example, the recently updated ASA Statement on Nonoperating Room Anesthetizing Locations generally focuses only on essential safety equipment and does not provide any recommendations on the ergonomics or efficiency of NORA care.16 The increasing role of NORA may prompt the ASA and other professional associations to advocate for procedural areas that take into account not only the essential safety, but also the ergonomics of anesthesia care. Assignment of an appropriate number of anesthesiologists should also be addressed given the concerns related to availability of anesthesiology services in at least some NORA locations17 and high demand for anesthesiologists.18
High demand for anesthesiologists outside of the OR is also reflected in the fact that the frequency of cases started after normal working hours was approximately 1.7 times greater in NORA compared with OR locations. Such a finding suggests that a considerable number of cases are performed by anesthesiologists in NORA environment with further limitations in available resources after normal working hours. Suboptimal case planning and frequent add-on cases may contribute to greater frequency of after-hours cases in NORA. The addition of emergency cases is a less likely explanation of greater frequency of after-hours NORA cases in this study, because the proportions of cases performed on weekends and official holidays, typically emergency cases, were comparable between NORA and OR locations.
We demonstrated a strong upward trend in the mean age of NACOR patients undergoing NORA: with each subsequent year of the study period, the mean age of NORA patients increased by more than a year. Such a trend was significantly greater than the upward trend in the mean age of OR patients. An upward trend in mean age of NORA patients is unlikely to be due to increasing life expectancy alone,19 since the annual increase in mean patient age in this study considerably exceeds the magnitude of life expectancy gained in the United States during the same time period.20 An upward trend in age observed in NACOR patients may be true for all NORA patients in the United States. It is also possible that the magnitude of the upward trend in mean patient age is affected by sampling bias if the true mean age of NORA patients in the United States is greater than that of the NACOR sample. An increase in sample size from 2010 to 2014 might have gradually brought the NACOR mean age estimates closer to the higher true mean value, thus creating a spurious trend. By contrast, if the true mean age of NORA patients in the United States is lower than in our sample, the annual increase in the mean age of patients in this study may be an underestimate. An upward trend in the mean age of patients receiving anesthesia care is concerning since older age is a known perioperative risk factor.21,22 Thus, it would be important to assess for increased complication rates that might parallel an upward trend in age.
Our study indicates that a large proportion of NORA patients are of advanced age. Approximately one third of patients in this analysis were aged 65 years and older, and a similar proportion of advanced endoscopy patients were aged 71 years and older in an earlier study.23 The difference in mean age between this analysis and the latter study of adult patients was expected since we analyzed both adult and pediatric cases. Older age may potentially explain the higher proportion of patients with ASA PS III–V in NORA compared with OR. Other factors, however, such as medical condition requiring a procedure, are likely to affect the overall health status of NORA patients.
The age distribution of NORA cases is likely to be affected by the large number of endoscopic screening cases requiring anesthesia care. The American Cancer Society Guidelines for the Early Detection of Cancer recommend screening colonoscopy at the age of 50 years with repeated colonoscopies performed each decade of life.24 Adherence to such guidelines in clinical practice may explain a larger proportion of patients aged 50 years and older in NORA group compared with OR cases. Our results suggest that NORA gastroenterology cases were the most frequent case type among NORA cases which had a specified location of anesthesia services in NACOR database. Furthermore, in our analysis, colonoscopy accounted for the majority of cases requiring NORA with more than 10 times greater absolute number of cases compared with the most common procedures in NORA cardiology and NORA radiology. Data from earlier studies also indicate that gastroenterology suites accounted for the largest number of legal claims among procedures performed outside of the OR.7
In this study and in a previously described advanced endoscopy cohort,23 patients with ASA PS I and II constituted the majority of NORA patients; however, the proportion of patients with ASA PS III–V was greater among NORA cases compared with OR cases. These results are consistent with observations from an analysis of closed legal claims in the United States, which demonstrated that most NORA claims involved older patients with greater disease severity than OR-related claims.7 The authors of the latter study also concluded that NORA poses a significant risk for patients. We found that a larger proportion of NORA cases were started after normal working hours, compared with OR cases. Such a finding may potentially explain greater periprocedural risk in NORA cases as the result of limited personnel and resources after normal working hours. We observed the lowest proportion of patients with ASA PS III–V in 2011. The lowest proportion of outpatient cases was also in 2011. The reason for such a co-occurrence is unclear.
We obtained data from NACOR, the largest and most comprehensive national anesthesia database. This study included a large number of NORA cases, and the results of this analysis are likely generalizable, because our data were obtained from NORA cases performed in a broad range of patients, in multiple settings, and with anesthesia personnel of various experience levels. Ongoing accumulation of data in NACOR will enable continued observation of the identified trends in the proportion of NORA cases and characteristics of NORA patients.
The type and volume of data contained in NACOR offer excellent opportunities for descriptive research but result in methodologic limitations. The lack of a standardized data collection procedure or a standardized set of outcome definitions, at least at present, makes NACOR data heterogeneous. We had to exclude from analysis a large number of cases as the result of missing data on the location of anesthesia care. It was not possible to impute the location of anesthesia care, because the vast majority of such cases also were missing data on the type of procedure. Selection bias, however, is unlikely to have a major effect on our main findings since time trends in characteristics of excluded cases were similar to those observed in the main analysis.
Also, we did not include cases of obstetric anesthesia, because the demographic and clinical characteristics of obstetric patients differ considerably from those of most NORA patients. We did not have a specific definition for cases with location of care reported as “mixed,” although the number of such cases was small compared with the size of the analyzed sample. Our study does not address concerns about the safety of NORA or specific patient outcomes, because we chose to focus on the relative volume of NORA cases and its change over time. The question of how representative NACOR is as a sample of all anesthesia cases nationwide remains unanswered at this time.
The results of this study offer an insight into nonoperating room anesthesia care in the United States. Available data suggest that approximately one third of all cases reported to NACOR are NORA cases. The proportion of cases performed outside of the OR has been increasing steadily during the study period. We also have identified a significant upward trend in the age of patients receiving NORA care. NORA cases were different from OR cases in a number of aspects. The frequency of cases started after normal working hours was higher in NORA compared with OR locations. Our results demonstrate that NORA is a rapidly growing component of anesthesiology practice. Data collected by NACOR in the coming years will further characterize the trends identified in this study.
Name: Alexander Nagrebetsky, MD, MSc.
Contribution: This author helped to design the study, collect the data, analyze the data, interpret findings, and prepare the manuscript.
Name: Rodney A. Gabriel, MD.
Contribution: This author helped to design the study and prepare the manuscript.
Name: Richard P. Dutton, MD, MBA.
Contribution: This author helped to design the study, collect the data, interpret findings, and prepare the manuscript.
Name: Richard D. Urman, MD, MBA.
Contribution: This author helped to design the study, collect the data, interpret findings, and prepare the manuscript.
This manuscript was handled by: Nancy Borkowski, DBA, CPA, FACHE, FHFMA.
1. Ferrari LR. Anesthesia outside the operating room. Curr Opin Anaesthesiol. 2015;28:439–440.
2. Chang B, Urman RD. Non-operating room anesthesia: the principles of patient assessment and preparation. Anesthesiol Clin. 2016;34:223–240.
3. Kolker A, Mascarenhas J. Anesthesia for outfield procedures in cancer patients. Curr Opin Anaesthesiol. 2015;28:464–468.
4. Van De Velde M, Kuypers M, Teunkens A, Devroe S. Risk and safety of anesthesia outside the operating room. Minerva Anestesiol. 2009;75(5):345–348.
5. Evron S, Ezri T. Organizational prerequisites for anesthesia outside the operating room. Curr Opin Anaesthesiol. 2009;22:514–518.
6. Chang B, Kaye AD, Diaz JH, Westlake B, Dutton RP, Urman RD. Complications of non-operating room procedures: outcomes from the national anesthesia clinical outcomes registry. J Patient Saf 2015; Epub ahead of print.
7. Metzner J, Posner KL, Domino KB. The risk and safety of anesthesia at remote locations: the US closed claims analysis. Curr Opin Anaesthesiol. 2009;22:502–508.
8. Beach ML, Cohen DM, Gallagher SM, Cravero JP. Major adverse events and relationship to nil per os status in pediatric sedation/anesthesia outside the operating room: a report of the pediatric sedation research consortium. Anesthesiology. 2016;124:80–88.
9. Verma V, Beethe AB, LeRiger M, Kulkarni RR, Zhang M, Lin C. Anesthesia complications of pediatric radiation therapy. Pract Radiat Oncol. 2016;6:143–154.
10. Porter ME. What is value in health care? N Engl J Med. 2010;363:2477–2481.
11. Dutton RP. Making a difference: the anesthesia quality institute. Anesth Analg. 2015;120:507–509.
12. Campbell K, Torres L, Stayer S. Anesthesia and sedation outside the operating room. Anesthesiol Clin. 2014;32:25–43.
13. Avalere Health analysis of American Hospital Association Annual Survey data for community hospitals. 2010.Washington, DC: Avalere Health, American Hospital Association;
14. Gurses AP, Ozok AA, Pronovost PJ. Time to accelerate integration of human factors and ergonomics in patient safety. BMJ Qual Saf. 2012;21:347–351.
15. Siegrist RB Jr.. Financial and operational analysis of non-operating room anesthesia: the wrong way versus the right way. Anesthesiol Clin. 2009;27:17–23.
16. American Society of Anesthesiologists. Statement on Nonoperating Room Anesthetizing Locations. Standards and Practice Parameters Committee; 2013.
17. Delva NJ, Graf P, Patry S, et al. Access to electroconvulsive therapy services in Canada. J ECT. 2011;27(4):300–309.
18. Gilron I, Delva N, Graf P, et al. Canadian survey of perianesthetic care for patients receiving electroconvulsive therapy. J ECT. 2012;28:219–24.
19. Verguet S, Jamison DT. Improving life expectancy: how many years behind has the USA fallen? A cross-national comparison among high-income countries from 1958 to 2007. BMJ Open. 2013;3(7):10.1136/bmjopen,2013–002814. Print 2013.
20. Raftery AE, Chunn JL, Gerland P, Sevčíková H. Bayesian probabilistic projections of life expectancy for all countries. Demography. 2013;50:777–801.
21. Bentrem DJ, Cohen ME, Hynes DM, Ko CY, Bilimoria KY. Identification of specific quality improvement opportunities for the elderly undergoing gastrointestinal surgery. Arch Surg. 2009;144:1013–1020.
22. Allen J, North JB, Wysocki AP, Ware RS, Rey-Conde T. Surgical care for the aged: a retrospective cross-sectional study of a national surgical mortality audit. BMJ Open. 2015;5:e006981.
23. Guimaraes ES, Campbell EJ, Richter JM. The safety of nurse-administered procedural sedation compared to anesthesia care in a historical cohort of advanced endoscopy patients. Anesth Analg. 2014;119:349–356.
© 2017 International Anesthesia Research Society
24. American Cancer Society. Guidelines for the Early Detection of Cancer. 2015.Atlanta, GA: American Cancer Society;